glp 1 for ulcerative colitis and GLP-1 medications are a major focus scientists right now., Here’s what’s happening: between 2024 and 2025, at least six studies have been published in respected journals Ulcerative colitis: signaling pathways, therapeutic
Description
In vivo, owing to DPP-4 intervention, GLP-1s biological half-life is just 1 to 2 minutes
Important note: The Dexcom Stelo is not recommended for people who experience problematic hypoglycemia (frequent dangerous lows)
GLP-1 medications can cost over $1000 per month without insurance
The biggest trial, STEP-1, included over 1900 overweight and obese individuals without T2D, with two-thirds of these volunteers administered 2.4mg/weekly semaglutide
Longer hold times allow more compound to cross
Understanding the cardiovascular effects of dual agonism compared to single GLP-1 receptor activation will be important for determining the clinical value of the additional complexity and cost associated with tirzepatide therapy
